REG - Optima Health PLC - Result of AGM

Optima HealthAnnouncement

01/09/2025 16:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250901:nRSA5220Xa&default-theme=true

RNS Number : 5220X  Optima Health PLC  01 September 2025

 

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

 

Result of Annual General Meeting

LONDON, UK, 1 September 2025, Optima Health (AIM: OPT), the UK's leading
provider of technology enabled corporate health and wellbeing solutions, today
announces that all proposed resolutions were duly passed at its Annual General
Meeting ("AGM"), held at 12pm BST, today 1 September.

 

The full proxy results of the AGM meeting will shortly be provided in the
Investor Relations section of the Company's website at
 www.optimahealth.co.uk (http://www.optimahealth.co.uk/)

 

 

Enquiries

 

 Optima Health                                       +44(0)3300085113

 Jonathan Thomas, CEO                                media@OptimaHealth.co.uk

 Heidi Giles, CFO

 Nominated Adviser and Corporate Broker

 Panmure Liberum Limited                             +44 (0)20 3100 2000

 Emma Earl / Will Goode/ Mark Rogers

 Rupert Dearden

 UK Financial PR Adviser                             optimahealth@icrinc.com

 ICR Healthcare

 Mary-Jane Elliott / Angela Gray / Lindsey Neville

 

 

About Optima Health

Optima Health is the UK's leading provider of occupational health and
wellbeing services, directly influencing and improving people's lives for over
25 years. The Group operates across the UK and Ireland, delivering to over 5
million employees across more than 2,000 clients. For more information visit
www.optima health.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGUARVRVSUKRAR